This paper investigated the use of salivary specimens for detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19) in patients with SARS-CoV-2 positive nasopharyngeal specimens and investigated if SARS-CoV-2 was detected in a patient’s salivary specimen after the nasopharyngeal specimen became negative. The effect of period since onset of symptoms, lactate dehydrogenase (LDH) levels, ultrasensitive C-reactive protein (us-CRP) levels, patient age, patient sex, drug intake, and the presence of comorbidities on SARS-CoV-2 cycle threshold (CT) value was also investigated.
Saliva is a reliable tool to detect SARS-CoV-2.
Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina DD, Genoni A, Fasano M, Sessa F, Tettamanti L, Carinci F, Maurino V, Rossi A, Tagliabue A, Baj A
Purpose
Conclusion
SARS-CoV-2 was detected in the initial saliva specimen from all 25 patients. The authors state there was no effect of period since onset of symptoms on salivary SARS-CoV-2 CT observed; however, regression analysis showed salivary RT-PCR values for SARS-CoV-2 were inversely correlated with LDH but not with us-CRP levels, patient age, patient sex, drug intake, or the presence of comorbidities. The authors state there were no relevant differences in SARS-CoV-2 CT between the first and second salivary collection. Importantly, the authors report positive salivary specimens for 2 or more days after the nasopharyngeal specimen became negative.
Studies (1)
Purpose
This study investigated the use of salivary specimens for detection of SARS-CoV-2 in patients with SARS-CoV-2 positive nasopharyngeal specimens and investigated if SARS-CoV-2 was detected in a patient’s salivary specimen after the nasopharyngeal specimen became negative. The effects of period since onset of symptoms, LDH levels, us-CRP levels, patient age, patient sex, drug intake, and the presence of comorbidities on SARS-CoV-2 CT value was also investigated. Saliva was collected using the drooling method or intraorally using a pipette from 25 hospitalized patients (17 male and 8 female, age 39-85) with severe or very severe infections with SARS-CoV-2 diagnosed by nasopharyngeal swabs. A second saliva specimen was collected from eight patients 4 days later. Saliva was resuspended in PBS and RNA was extracted using the QIAmp Viral RNA Mini Kit and subjected to one-step RT-PCR using the Luna Universal qPCR Master Mix and primer for the 5’UTR of SARS-CoV-2. Specimens were classified as highly positive or low positive based on having a CT value below or above the median CT, respectively. Method of us-CRP and LDH determination was not specified.
Summary of Findings
SARS-CoV-2 was detected in the initial saliva specimen from all 25 patients. The authors state there was no effect of period since onset of symptoms on salivary CT observed; however, regression analysis showed salivary RT-PCR values for SARS-CoV-2 were inversely correlated with LDH (β=-0.02, P= 0.04) and average LDH levels were significantly lower in male patients than female patients (304.3 versus 400.6, P=0.025). SARS-CoV-2 CT values were not significantly associated with us-CRP levels, patient age, patient sex, drug (anticoagulants, ACE-inhibitors, or statins) intake, or the presence of comorbidities such as dyslipidemia, hypertension, or obesity. The authors state there were no relevant differences in SARS-CoV-2 CT between the first and second salivary collection. Importantly, the authors report positive salivary specimens for 2 or more days after the nasopharyngeal specimen became negative.
Biospecimens
FluidSalivaCellNasopharynxPreservation Types
None (Fresh)Diagnoses
Pneumonia/Respiratory InfectionPlatforms
RNAReal-time qRT-PCRProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs ACE-inhibitorsAnticoagulantsStatinsPreaquisition Patient age 39-85 years oldPreaquisition Patient gender FemaleMalePreaquisition Prior patient medical condition Existing dyslipidemia, hypertension, or obesityBiospecimen Acquisition Biospecimen location NasopharynxSalivaBiospecimen Acquisition Time of biospecimen collection Current positive nasopharyngeal swabDay nasopharyngeal swab converted to negativeTwo days after nasopharyngeal swab converted to negativeUnspecified duration since onset of symptomsReal-time qRT-PCR Specific Targeted nucleic acid SARS-CoV-2